Table 1. Ability of decitabine-treated wound epithelia to participate in blastema formation.

Treatment	Total	1° Blastema	No Blastema	2° Blastema
Decitabine	6	4 (67%)	2 (33%)*	0 (0%)
2’-deoxycytidine (control)	8	1** (12%)	5 (63%)	2 (25%)

* The presence of a decitabine bead could not be confirmed 24 hour after grafting in two additional wounds that did not form an ectopic blastema (a total of 8 limbs were grafted), and those data were not included.

** A tear in the WE/AEC of this wound that re-healed and formed a new WE/AEC was observed 24 hours after grafting.